Drawing for EPIT

USPTO serial 79339892

EPIT

Reviewed by CopyMark Law Group

Reg. 7318031Status 404
Filing date
Status date
Registration date
Mar 5, 2024
Examiner
SIEGEL, PAIGE JORDAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EPIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey A. Smith

Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201

Goods and services

ClassDescriptionStatusFirst use
042Research in the field of immunotherapy; designing a scientific method for desensitization via epicutaneous immunotherapy applied to clean and dry skin, without the skin being pre-prepared that leaves the cell structure of epidermis intact; scientific research in the field of allergy treatments and therapies; scientific research relating to allergy treatments that are repeatedly applied to the clean and dry skin without the skin being pre-prepared that leaves the cellular structure of the epidermis intact, to allow allergen to be presented to the skin immune cell whilst limiting allergen entering from getting into the bloodstream; medical research services, namely, discovery and development of allergens; designing medical treatment methods for allergies by associating allergens to immune cells present in the skin; designing medical treatment methods for allergies consisting of the application of a patch on the intact clean and dry skin of the patient without the skin being pre-prepared that leaves the cellular structure of the epidermis intactSECTION 70 - CANCELLED
044Medical services consisting of the application of a desensitization method using immunotherapy; medical treatments of allergies comprising the administration of allergens by putting a patch on the intact skin of a patient to prevent the allergen from getting into the blood; medical treatments of allergies using desensitization via epicutaneous immunotherapy; epicutaneous medical treatments of allergies applied to clean and dry skin without the skin being pre-prepared that leaves the cellular structure of the epidermis intact; medical consulting in the field of desensitizing against allergiesSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 27, 2025DETHDEATH OF INTERNATIONAL REGISTRATION
Jul 17, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 20, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 5, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 2, 2024GPNXNOTIFICATION PROCESSED BY IB
Dec 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 29, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 11, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 11, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 12, 2023RFNTREFUSAL PROCESSED BY IB
Mar 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 14, 2023RFRRREFUSAL PROCESSED BY MPU
Jan 21, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 25, 2022DOCKASSIGNED TO EXAMINER
Jun 17, 2022RNWLINTERNATIONAL REGISTRATION RENEWED
May 10, 2022MAFRAPPLICATION FILING RECEIPT MAILED
May 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance